From rising costs to changing demographics and complex ecosystems, the healthcare market has become an interesting place for investors to put their money into.
There is a wide array of offerings from innovative care to advanced digital technologies from every corner of the market assessing just about any patients’ needs, many of which have yet to be fully put into practice, which makes for an engaging “ground floor” investment opportunity.
The global healthcare market is expected to grow at a compound annual growth rate (CAGR) of 8.9% to nearly $11,908.90 billion (USD) by 2022, according to a recent report by ResearchAndMarkets.com titled “Healthcare Global Market Opportunities and Strategies to 2022”.
Here are several intriguing prospects in healthcare, each with their own unique proposition worthy of your due diligence:
Vertex Pharmaceuticals (NASDAQ: VRTX) - A global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis.
Data gathered from the Cystic Fibrosis Foundation Patient Registry found that more than 70,000 people live with cystic fibrosis worldwide, with more than 30,000 people in the United States alone.Approximately 1,000 new cases of CF are diagnosed each year.
Anthem Inc. (NYSE: ANTM) - A health benefits company dedicated making healthcare simpler. Through its affiliated companies, Anthem serves more than 77 million people, including over 40 million within its family of health plans.
The company was recently named one of the US’ most JUST Companies for 2020, according to Forbes and JUST Capital, one of the leading corporate measurement platforms for the multi-stakeholder economy.
Takeda Pharmaceuticals (NYSE: TAK) - A global research and development biopharmaceutical company headquartered in Japan, TAK translates science into highly-innovative medicines.
The company focuses its R&D efforts on four therapeutic areas:
-
Oncology
-
Rare Diseases
-
Neuroscience
-
Gastroenterology (GI)
TAK also makes targeted R&D investments in Plasma-Derived Therapies and Vaccines.
In January 2020, Takeda was named among the top 100 global sustainable corporations for the fifth year in a row.
There are a great many other companies in the healthcare space worth investigating further, such as Repligen (NASDAQ: RGEN), Edwards Lifesciences (NYSE: EW) and DaVita Inc. (NYSE: DVA), to name a few. Do you have any success stories in the healthcare market? Let us know in the comments below.
To learn about some of the most-talked about Healthcare stocks on Stockhouse, check out the Healthcare Bullboards.
For more of the latest info on Healthcare stocks, check out the Healthcare Trending News hub on Stockhouse.